Education
About Us
Working with TipRanks
Follow Us
TherapeuticsMD (TXMD)
NASDAQ:TXMD
Total Valuation
TherapeuticsMD has a market cap or net worth of $16.78M. The enterprise value is $17.58M.
Market Cap$16.78M
Enterprise Value$17.58M
Share Statistics
TherapeuticsMD has 11,574,362 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,574,362
Owned by Insiders1.48%
Owned by Institutions21.63%
Financial Efficiency
TherapeuticsMD’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -13.31%.
Return on Equity (ROE)-0.08
Return on Assets (ROA)-0.06
Return on Invested Capital (ROIC)-13.31%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee1.76M
Profits Per Employee-2.18M
Employee Count1
Asset Turnover0.05
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of TherapeuticsMD is -4.55. TherapeuticsMD’s PEG ratio is ―.
PE Ratio-4.55
PS Ratio0.00
PB Ratio0.65
Price to Fair Value0.36
Price to FCF11.28
Price to Operating Cash Flow11.26
PEG Ratio―
Income Statement
In the last 12 months, TherapeuticsMD had revenue of 1.76M and earned -2.18M in profits. Earnings per share was -0.19.
Revenue1.76M
Gross Profit1.25M
Operating Income-4.76M
Pretax Income-2.34M
Net Income-2.18M
EBITDA-1.83M
Earnings Per Share (EPS)-0.19
Cash Flow
In the last 12 months, operating cash flow was 1.54M and capital expenditures 0.00, giving a free cash flow of 1.54M billion.
Operating Cash Flow1.54M
Free Cash Flow1.54M
Free Cash Flow per Share0.13
Dividends & Yields
TherapeuticsMD pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.53
52-Week Price Change-32.27%
50-Day Moving Average1.15
200-Day Moving Average1.31
Relative Strength Index (RSI)67.69
Average Volume (3m)40.57K
Important Dates
TherapeuticsMD upcoming earnings date is Aug 18, 2025, TBA Not Confirmed.
Last Earnings DateMay 13, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―
Financial Position
TherapeuticsMD as a current ratio of 2.37, with Debt / Equity ratio of 22.29%
Current Ratio2.37
Quick Ratio2.37
Debt to Market Cap0.00
Net Debt to EBITDA-1.15
Interest Coverage Ratio0.00
Taxes
In the past 12 months, TherapeuticsMD has paid -31.00K in taxes.
Income Tax-31.00K
Effective Tax Rate0.01
Enterprise Valuation
TherapeuticsMD EV to EBITDA ratio is -6.56, with an EV/FCF ratio of 10.29.
EV to Sales6.83
EV to EBITDA-6.56
EV to Free Cash Flow10.29
EV to Operating Cash Flow10.29
Balance Sheet
TherapeuticsMD has $5.75M in cash and marketable securities with $5.96M in debt, giving a net cash position of $215.00K billion.
Cash & Marketable Securities$5.75M
Total Debt$5.96M
Net Cash$215.00K
Net Cash Per Share$0.02
Tangible Book Value Per Share$2.00
Margins
Gross margin is 93.09%, with operating margin of -270.30%, and net profit margin of -123.85%.
Gross Margin93.09%
Operating Margin-270.30%
Pretax Margin-133.05%
Net Profit Margin-123.85%
EBITDA Margin-104.15%
EBIT Margin-198.30%
Analyst Forecast
The average price target for TherapeuticsMD is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast35.25%
EPS Growth Forecast81.05%